Varied Coronavirus Antibodies Cast Doubt on Immunity
World Health Organization members on Monday stated that coronavirus antibodies vary among patients from robust to even non-existent. The findings are raising serious doubts about the durability of individuals’ immunity, if present at all, to re-infection from the SARS-CoV-2 Severe Respiratory Syndrome virus that causes COVID-19.
In addition, these WHO officials also stated that relapse of illness from the initial infection is not out of the question.
As already seen in some early reports out of Wuhan, it appears that it may be possible for some who have been listed as ‘recovered’ to get sick again. This may suggest that coronavirus antibodies have not built up sufficiently in those infected to fend off another bout of illness.
Dr. Mike Ryan, executive director of WHO’s emergencies program:
“There are many reasons why we might see reactivation of infection either with the same infection or another infectious agent…
there are many situations in viral infection where someone doesn’t clear the virus entirely from their system.”
Study: 36% of Patients did not Develop Many Coronavirus Antibodies
In a new study of (at least initially) recovered SARS-CoV-2 patients , 6% of subjects did not develop antibodies at all, and another 30% were shown to have only very low levels of antibodies present after infection.
The study did suggest that while in individuals where coronavirus antibodies were hardly found, if found at all, it was possible those patients still recovered thanks to “other immune responses, including T cells or cytokines.”
“What this will mean to herd immunity will require more data from other parts of the world,” Huang Jinghe, research team leader said to the South China Morning Post.
Interestingly, those roughly middle-age and older appear to have devleoped higher levels of the coronavirus antibodies.
Here at TrumpSlump.World we have decided to refocus the homepage to news and updates more about the world economy, from the initial Trump Slump to the very first signs of outright recessions country-by-country, region-by-region, and now the shock from COVID19.
This article is being included in the home page as it potentially has large implications for how quickly we can hope to return to a COVID-free world, or at least something that resembles it, and because we believe the topic of coronavirus antibodies is one of overreaching public health interest.